Analystreport

Orchard Therapeutics PLC - (NASDAQ: ORTX) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "strong-buy" rating. They now have a $15.00 price target on the s...

Orchard Therapeutics plc - American Depositary Shares  (ORTX) 
Last orchard therapeutics plc - american depositary shares earnings: 2/27 07:00 am Check Earnings Report